INTRODUCTION
Amnioinfusion is reported to improve neonatal outcomes in cases of meconium-stained amniotic fluid, 1,2 severe repetitive variable fetal heart rate decelerations, 3, 4 premature rupture of the membranes, 4, 5, 7 and oligohydramnios. 4, 6 Specific methods for the procedure vary, but usually involve the instillation of physiologic solutions such as lactated Ringer's or normal saline into the amniotic cavity. 7 Little is known about the effects of the amnioinfused solution on neonatal plasma electrolyte concentrations or pH. Amniotic fluid electrolytes include sodium of 124 to 126 mEq/l, chloride of 103 to 108 mEq/l, and potassium of 3.9 to 4.5 mEq/l. 8 These values more closely resemble that of lactated Ringer's solution. Normal saline has an electrolyte composition of sodium 154 mEq/l, chloride 154 mEq/l, and no potassium. In the fetal sheep model, Shields et al. 9 demonstrated that the use of normal saline for amnioinfusion is associated with significant changes in fetal plasma electrolyte concentrations and pH. Similar findings are not documented in human subjects. 10 -12 This prospective randomized trial evaluated whether the use of lactated Ringer's solution or normal saline solution for amnioinfusion was associated with clinically significant changes on neonatal plasma electrolyte concentrations or pH. Use of normal saline solution may be associated with neonatal hypernatremia and acidosis.
MATERIALS AND METHODS
Forty women admitted to the University of New Mexico Health Sciences Center in active labor with particulate meconium-stained amniotic fluid enrolled for the study. All had singleton, term pregnancies (37-42 weeks) with fetuses in cephalic presentation and electronic fetal heart tracings not displaying variable or late decelerations. The fetal heart rate baseline was between 120 and 160 beats/min. A group of 21 women at term who did not receive amnioinfusion and who had no pregnancy complications was the control group. All the women received intravenous lactated Ringer's solution at 125 ml/hr in accordance with the Labor and Delivery Unit protocol. After informed consent, the women were randomized to receive amnioinfusion with either normal saline solution or lactated Ringer's solution. Randomization was performed by a
OBJECTIVE:
To determine if amnioinfused normal saline or lactated Ringer's solution in cases of meconium -stained amniotic fluid is associated with significant changes on neonatal plasma electrolyte concentrations or pH.
STUDY DESIGN:
This was a prospective randomized study using normal saline or lactated Ringer's solution for amnioinfusion in women with thick meconium in the amniotic fluid. The control group was composed of women with clear amniotic fluid not receiving amnioinfusion. Cord blood arterial sampling was analyzed for sodium, potassium, and chloride plasma concentrations and pH. The sample sizes allowed for an of 0.05 and power of 0.80.
RESULTS:
We evaluated 61 cases ( 20 normal saline solution, 20 lactated Ringer's solution, and 21 control ). No significant differences in cord blood arterial plasma concentrations of sodium ( p = 0.43 ), potassium ( p = 0.21 ), chloride ( p = 0.68 ), and pH ( p = 0.11 ) were noted. 
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computer-generated schedule sealed in envelopes. Our institutional review board approved the study protocol. The sample size was calculated based on a 10% increase in the incidence of significant hypernatremia (sodium >155 mEq/l). With an =0.05 and power of 0.80, 20 patients were needed per group. Statistical analyses were performed using one-way analysis of variance, regression analysis, and t-test. A p value less than 0.05 was considered significant.
Each woman received an initial bolus infusion of 400 ml over the first hour followed by a constant 150 ml/hr infusion. The solutions were at room temperature and infused by gravity. Management of labor was left to the discretion of the attending physician.
Data collected included maternal demographics and duration of labor for all women. The total volume and the duration of the amnioinfusion were recorded. At delivery, cord blood arterial samples were obtained and analyzed for pH and for sodium, potassium, and chloride plasma concentrations. The blood samples were taken to the hospital laboratory immediately after being drawn. Qualified laboratory personnel processed the blood samples within 30 minutes of being received using automated laboratory equipment.
RESULTS
There was no significant difference among the groups for maternal age, gravidity, and duration of amnioinfusion, and for the total volume infused. Table 1 shows maternal demographics and characteristics for the three groups. Cesarean section rates, neonatal birth weights, and APGAR scores rates were similar for all groups. The 5-min APGAR score for all neonates was greater than seven.
The cord blood arterial plasma electrolyte concentrations and pH at birth were compared among the three groups ( Table 2 ). The plasma concentrations of sodium, potassium, and chloride and the pH were not significantly different among the groups.
DISCUSSION
Intrapartum amnioinfusion is reported to improve neonatal outcome in several clinical scenarios. 1 -6 It is a technique well accepted in clinical practice. Most clinicians use either normal saline solution or lactated Ringer's solution for amnioinfusion. It is important to determine if either solution is associated with adverse effects on neonatal plasma electrolyte concentrations or pH.
In a sheep model, the use of normal saline solution decreased the fetal plasma pH and increased sodium and chloride concentrations. 9 In contrast, this study did not reveal any significant changes in neonatal electrolyte concentration or cord blood artery pH among the groups. A control group not receiving amnioinfusion had similar electrolyte concentrations and umbilical artery blood pH levels.
This study differs from previously published reports by Puder et al., 10 Pressman and Blakemore, 11 and Washburne et al. 12 The Puder et al. and Washburne et al. studies did not specify whether arterial or venous cord blood samples were analyzed. This could potentially affect the results because there is the possibility that transplacental clearance normalizes plasma electrolyte level alterations. This study only used umbilical artery blood samples.
All the previously reported studies included women in whom amnioinfusion was used for the management of variable fetal heart rate decelerations. 10 -12 Variable fetal heart rate decelerations are Mean ± SD. LR = lactated Ringer's; NSS = normal saline; C = controls; p = p value.
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Amnioinfused Solutions associated with umbilical cord compression and could decrease the umbilical artery blood pH. We limited our study to cases in which amnioinfusion was given prophylactically for meconium-stained amniotic fluid and the fetal heart tracings showed no baseline abnormalities or decelerations.
As previously reported, 10 -12 the differences between the results of this study and the ovine model are probably due to different infusion rates and total volume infused. Shields et al. 9 used 6 l over a 1-hour period. This is a much larger volume than the 500 to 1500 ml total used in typical clinical protocols. The differences in vascularization between the sheep's amnion and chorion and that of a human placenta may also account for differences in absorption of the amniotic fluid into the fetal circulation.
